BTN3A2 and depressive symptom measurement: In vitro studies suggest that AU may exert therapeutic effects by decreasing the expression of CXCL10 and BTN3A2. There is a growing body of evidence supporting the role of adult neurogenesis in the pathology and physiology of brain homeostasis and depression (66).